2-Minute Drill: Closing Thoughts on the 2023 ASH Annual Meeting

EP: 1.2-Minute Drill: The Biggest Surprise From the 2023 ASH Annual Meeting

EP: 2.2-Minute Drill: The Most Practice-Changing Data From ASH 2023

EP: 3.2-Min Drill: ASH 2023 Data in Multiple Myeloma Slated for FDA Approval

EP: 4.2-Min Drill: ASH 2023 Data That Require the Most Follow-up

EP: 5.2-Min Drill: The Biggest Winner at the 2023 ASH Annual Meeting

EP: 6.2-Minute Drill: Shameless Plug From ASH 2023

Now Viewing

EP: 7.2-Minute Drill: Closing Thoughts on the 2023 ASH Annual Meeting

EP: 8.ASH 2023: The Most Relevant Multiple Myeloma Data Presented

Richter: Alright, getting into the homestretch. We touched on a lot today, and I really want to thank all of you so much. But before we get to tallying up the points and giving official bragging rights, 15 seconds each real quick, [what are your] closing thoughts? Dr Usmani, let's start with you.

Usmani: The future is bright, and the cure is near.

Faiman: How do I beat that? You got it in under 5 seconds and was exactly what I wanted to say. The excitement is real and the energy is palpable. Hopefully we will continue to keep on searching for the cure together.

Matous: Even though we're hematologists, we focus on myeloma, I always try to make it to the honorific lectures. I learned so much at them. I'm so humbled by the great work that these people are doing in fields about which I'm ignorant, and that's one of the reasons I love ASH so much.

Richter: Phenomenal, and right at the buzzer. I want to thank you all again. So I have to announce the winner, our winner of today's 2-Minute Drill. We actually have a 2-way tie! I have to congratulate Dr Faiman and Dr Usmani, who have tied to win, but you are all winners in my eyes.

That's all the time we have for today. Thank you so much for joining CancerNetwork for 2-Minute Drill, where we offer unscripted, rapid insight on the most recent cancer conferences. I'm your host, Dr Joshua Richter, have a great day.